Directive 65/65/EEC

Directive 65/65/EEC1 was the first European pharmaceutical directive. (Dated 26 January 1965.)

Intention

The directive was a reaction to the Thalidomide tragedy in the early 1960s, when thousands of babies were born with deformities as a result of their mothers taking the drug during pregnancy. The directive aimed at harmonising standards for the approval of medicines within the then European Economic Community

Regulation

The main article 3 of the directive requires that a Proprietary medicinal product could not be marketed within the community without prior authorisation of the competent authority of at least one member state. Proprietary medicinal product being defined as "Any ready-prepared medicinal product placed on the market under a special name and in a special pack."

gollark: This server was split off from it in the wake of this due to people retroactively interpreting palaiologistic behavior as showing that they are not interested in listening to their community.
gollark: Approximate and heavily biased summary: palaiologos suddenly demanded that all (future?) events not require specifically Python after being annoyed by HelloBoi's event somehow and apparently past ones, and ubq shut down the code guessing event and left.
gollark: Weren't you one of the primary supporters, even?
gollark: Didn't you vote for lyric demotion?
gollark: I like how the artificial intelligences are above all other users.

See also

References
  • Maio G., On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation, Dtsch Med Wochenschr. 2001 October 19;126(42):1183-6.
  • Shah RR., Thalidomide, drug safety and early drug regulation in the UK, Adverse Drug React Toxicol Rev. 2001 Dec;20(4):199-255.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.